Spinal cord stimulation (SCS) for treatment of chronic pain in the back and/or lower extremities is associated with greater improvements in pain compared with conventional medical management (CMM), according to a review. published online Nov. 14 in JAMA Network Open,
Frank JPM Huygen, Ph.D., MD, from Erasmus Medical Center in Rotterdam, Netherlands, and colleagues conducted a systematic literature review and network meta-analysis to evaluate the efficacy of SCS therapies compared to CMM.
Based on 13 included studies (1,561 patients), the researchers found that both conventional and novel SCS therapies were associated with superior efficacy versus CMM in responder rates for pain reduction in the back (conventional SCS: odds ratio (OR), 3.00; novel SCS : OR, 8.76), pain intensity in the back (conventional SCS: mean difference (MD), −1.17; novel SCS: MD, −2.34), pain intensity in the leg (conventional SCS: MD, −2.89; novel SCS: MD, −4.01), and the EQ-5D index score (conventional SCS: MD, 0.15; novel SCS: MD, 0.17). Conventional SCS was superior to CMM for functional disability (MD, −7.10).
“Our study provides important insights for clinical decision-making as well as assessment by health technology agencies based on a more representative evidence base and a more inclusive analytical framework than that reported by prior reviews comparing SCS technologies,” the authors write.
More information:
Frank JPM Huygen et al, Spinal Cord Stimulation vs Medical Management for Chronic Back and Leg Pain, JAMA Network Open (2024). DOI: 10.1001/jamanetworkopen.2024.44608
2024 Health Day. All rights reserved.
Citation: Spinal cord stimulation holds promise for chronic pain (2024, November 20) retrieved 20 November 2024 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
